hepatotoxicity – mycolab.ai

Ganoderma lingzhi (Reishi Mushroom)-Induced Acute Liver Injury in the Setting of Alcohol Use: A Case Report and Review of the Literature

mycolabadmin

A 47-year-old man developed severe liver inflammation after consuming Reishi mushroom powder while drinking large amounts of vodka over three days. Although Reishi mushrooms are commonly promoted as healthy supplements, in this case the combination with alcohol caused his liver enzymes to spike dangerously high. The patient recovered after hospital treatment, but the case highlights that even natural supplements can be harmful, especially when combined with alcohol. This raises concerns that more research is needed on how mushroom supplements interact with other substances people consume.

Inonotus obliquus aqueous extract prevents histopathological alterations in liver induced by environmental toxicant Microcystin

mycolabadmin

This research shows that Chaga mushroom extract can protect the liver from damage caused by microcystin, a toxic chemical produced by cyanobacteria in water. When mice were exposed to microcystin, their livers became damaged, but treating them with Chaga mushroom extract restored normal liver function and prevented cell death. The study suggests Chaga mushroom could be used as a natural supplement to prevent liver toxicity from environmental pollutants.

Acute liver failure caused by Amanita verna: a case series and review of the literature

mycolabadmin

This case study examines three patients who became severely ill after eating poisonous Amanita verna mushrooms in China. One patient successfully received a liver transplant and recovered, while the other two died from brain bleeding complications. The study highlights that liver transplantation can be life-saving for mushroom poisoning victims with severe liver failure, though doctors need better guidelines to decide when transplantation is the right choice.

Liposomal amphotericin B prophylaxis in paediatrics: a systematic review

mycolabadmin

This review examined how well liposomal amphotericin B (a fungal medication) works to prevent serious fungal infections in children. Researchers looked at 20 studies involving over 2000 children and found that about 7% still developed fungal infections despite the medication, with common side effects being low potassium levels and liver problems. The main finding is that doctors use this medication in very different ways, and we need better research to figure out the best dosing strategy for children.

Herbal Supplement-Induced Liver Injury: A Case Report

mycolabadmin

A 45-year-old woman developed severe liver injury after drinking an herbal tea containing multiple ingredients, including reishi mushroom and aloe vera. Her liver function gradually improved after she stopped drinking the tea, with complete recovery within three months. This case demonstrates that herbal supplements, often perceived as safe, can cause serious liver damage and should be investigated when patients develop unexplained liver problems.

Efficacy and safety of isavuconazole for invasive fungal infections: A systematic review and meta-analysis of randomized controlled trials

mycolabadmin

This study reviewed clinical trials comparing a newer antifungal drug called isavuconazole with other commonly used antifungal medications for treating serious fungal infections, particularly in patients with weakened immune systems. The research found that isavuconazole works just as well as other antifungal drugs but may have fewer side effects, especially liver problems. When compared directly with voriconazole, isavuconazole showed fewer drug-related side effects overall, making it a good alternative option for patients who cannot tolerate other antifungal treatments.

Increasing incidence of mycotoxicosis in South-Eastern Germany: a comprehensive analysis of mushroom poisonings at a University Medical Center

mycolabadmin

This study examined mushroom poisoning cases in a German hospital from 2005 to 2022 and found that poisonings have nearly doubled in recent years, likely due to more people foraging for wild mushrooms and changes in climate affecting mushroom distribution. The death cap mushroom (Amanita phalloides) caused the majority of serious cases, leading to liver and kidney failure. Researchers found that a blood-cleansing treatment called plasmapheresis could help stabilize patients with life-threatening bleeding complications while they recovered or waited for a liver transplant.

Efficacy and safety of isavuconazole for invasive fungal infections: A systematic review and meta-analysis of randomized controlled trials

mycolabadmin

Isavuconazole is an antifungal medication used to treat serious fungal infections in people with weakened immune systems. This study reviewed and analyzed three clinical trials to compare how well isavuconazole works compared to other antifungal drugs. The results showed that isavuconazole is just as effective as other antifungals but has fewer side effects, particularly fewer problems with liver health and drug-related adverse events. This makes isavuconazole a good alternative choice for patients who cannot use other antifungal medications or who are at risk of liver damage.

Research Keyword: hepatotoxicity